Inhaled loxapine

DRUG4 trials

Sponsors

Alexza Pharmaceuticals, Inc., Lee's Pharmaceutical Limited

Conditions

Bipolar DisorderChronic Obstructive Pulmonary DiseaseHealthyPsychomotor AgitationSchizophreniaThorough QT/QTc Study

Phase 1

Staccato Loxapine Pulmonary Safety in Healthy Volunteers

CompletedNCT00789360

Alexza Pharmaceuticals, Inc.Healthy

Start: 2008-11-30End: 2009-04-30Updated: 2019-03-11

Staccato Loxapine Thorough QT/QTc Study

CompletedNCT00874237

Alexza Pharmaceuticals, Inc.Thorough QT/QTc Study

Start: 2009-04-30End: 2009-06-30Updated: 2019-10-30

Staccato Loxapine Pulmonary Safety in Patients With COPD

CompletedNCT00889837

Alexza Pharmaceuticals, Inc.Chronic Obstructive Pulmonary Disease

Start: 2009-06-30End: 2009-08-31Updated: 2017-03-14

Phase 3

A Study of Staccato Loxapine (ADASUVE®) for Inhalation

Lee's Pharmaceutical LimitedBipolar Disorder, Psychomotor Agitation, Schizophrenia

Start: 2019-12-01End: 2020-08-01Target: 150Updated: 2019-11-05